Our AI solution was selected for funding by the 2020 "Europe Innovative Medicines Initiative"

Our proprietary solution was nominated by Deep Pharma Intelligence as one of the "Top 11 AI Breakthroughs in Biopharma from 2018 to 2020"

Our pan-European collaborative project secured funding from the Dynamic Resilience program, launched by Wellcome Leap and Temasek Trust

Recognized as one of the "100 to Watch" in Forbes Asia's 2023 list

Fortune China IMPACT